Nigella sativa: A Potential Antiosteoporotic Agent

Ahmad Nazrun Shuid, Norazlina Mohamed, Isa Naina Mohamed, Faizah Othman, Farihah Suhaimi, Elvy Suhana Mohd Ramli, Norliza Muhammad, Ima Nirwana Soelaiman, Ahmad Nazrun Shuid, Norazlina Mohamed, Isa Naina Mohamed, Faizah Othman, Farihah Suhaimi, Elvy Suhana Mohd Ramli, Norliza Muhammad, Ima Nirwana Soelaiman

Abstract

Nigella sativa seeds (NS) has been used traditionally for various illnesses. The most abundant and active component of NS is thymoquinone (TQ). Animal studies have shown that NS and TQ may be used for the treatment of diabetes-induced osteoporosis and for the promotion of fracture healing. The mechanism involved is unclear, but it was postulated that the antioxidative, and anti-inflammatory activities may play some roles in the treatment of osteoporosis as this bone disease has been linked to oxidative stress and inflammation. This paper highlights studies on the antiosteoporotic effects of NS and TQ, the mechanisms behind these effects and their safety profiles. NS and TQ were shown to inhibit inflammatory cytokines such as interleukin-1 and 6 and the transcription factor, nuclear factor κB. NS and TQ were found to be safe at the current dosage for supplementation in human with precautions in children and pregnant women. Both NS and TQ have shown potential as antiosteoporotic agent but more animal and clinical studies are required to further assess their antiosteoporotic efficacies.

Figures

Figure 1
Figure 1
The two pathways which may lead to osteoporosis are shown, that is, activation of osteclastic bone resorption activity by free radicals and by inflammation. The inhibition of these two pathways by Nigella sativa or Thymoquinone, its active component, may account for the mechanisms involved in prevention of osteoporosis.

References

    1. Goreja WG. Black Seed: Natural Medical Remedy. New York, NY, USA: Amazing Herbs Press; 2003.
    1. Badary OA, Gamal El-Din AM. Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis. Cancer Detection and Prevention. 2001;25(4):362–368.
    1. Burits M, Bucar F. Antioxidant activity of Nigella sativa essential oil. Phytotherapy Research. 2000;14(5):323–328.
    1. Morsi NM. Antimicrobial effect of crude extracts of Nigella sativa on multiple antibiotics-resistant bacteria. Acta Microbiologica Polonica. 2000;49(1):63–74.
    1. Aljabre SHM, Randhawa MA, Akhtar N, Alakloby OM, Alqurashi AM, Aldossary A. Antidermatophyte activity of ether extract of Nigella sativa and its active principle, thymoquinone. Journal of Ethnopharmacology. 2005;101(1–3):116–119.
    1. Randhawa MA, Alaklobi OM, Ajabre SHM, et al. Thymoquinone, an active principle of Nigella sativa, inhibited Fusarium solani . Pakistan Journal of Medical Research. 2005;44(1):1–3.
    1. Boskabady MH, Shirmohammadi B. Effect of Nigella sativa on isolated guinea pig trachea. Archives of Iranian Medicine. 2002;5(2):103–107.
    1. Hadjzadeh MA, Khoei A, Hadjzadeh Z, Parizady M. Ethanolic extract of Nigella sativa L seeds on ethylene glycol-induced kidney calculi in rats. Urology Journal. 2007;4(2):86–90.
    1. Islam MT, Selim ASM, Sayed MA, et al. Nigella sativa L. supplemented diet decreases egg cholesterol content and suppresses harmful intestinal bacteria in laying hens. Journal of Animal and Feed Sciences. 2011;20:587–598.
    1. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa . Phytotherapy Research. 2003;17(4):299–305.
    1. Ghosheh OA, Houdi AA, Crooks PA. High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.) Journal of Pharmaceutical and Biomedical Analysis. 1999;19(5):757–762.
    1. Devareddy L, Khalil DA, Smith BJ, et al. Soy moderately improves microstructural properties without affecting bone mass in an ovariectomized rat model of osteoporosis. Bone. 2006;38(5):686–693.
    1. Devareddy L, Hooshmand S, Collins JK, Lucas EA, Chai SC, Arjmandi BH. Blueberry prevents bone loss in ovariectomized rat model of postmenopausal osteoporosis. Journal of Nutritional Biochemistry. 2008;19(10):694–699.
    1. He CC, Hui RR, Tezuka Y, Kadota S, Li JX. Osteoprotective effect of extract from Achyranthes bidentata in ovariectomized rats. Journal of Ethnopharmacology. 2010;127(2):229–234.
    1. Shuid AN, Ping LL, Muhammad N, Mohamed N, Soelaiman IN. The effects of Labisia pumila var. alata on bone markers and bone calcium in a rat model of post-menopausal osteoporosis. Journal of Ethnopharmacology. 2011;133(2):538–542.
    1. Valizadeh N, Zakeri HR, Shafiee A, et al. The effect of Nigella sativa extract on biochemical bone markers in osteopenic postmenopausal women. Iranian Journal of Endocrinology & Metabolism. 2009;10(6):570–580.
    1. Okazaki R. Diabetes mellitus and bone metabolism. Clinical Calcium. 2011;21(5):669–675.
    1. Pater A, Odrowąż-Sypniewska G. Alterations of bone metabolism in children and adolescents with diabetes mellitus type 1. The Pediatric Endocrinology Diabetes and Metabolism. 2011;17(3):158–161.
    1. Altan MF, Kanter M, Donmez S, Kartal ME, Buyukbas S. Combination therapy of Nigella sativa and human parathyroid hormone on bone mass, biomechanical behavior and structure in streptozotocin-induced diabetic rats. Acta Histochemica. 2007;109(4):304–314.
    1. Shady AM, Nooh HZ. Effect of black seed (Nigella sativa) on compact bone of streptozotocin induced diabetic rats. Egypt Journal of Histology. 2010;33(1):168–177.
    1. Tahraoui A, El-Hilaly J, Israili ZH, Lyoussi B. Ethnopharmacological survey of plants used in the traditional treatment of hypertension and diabetes in south-eastern Morocco (Errachidia province) Journal of Ethnopharmacology. 2007;110(1):105–117.
    1. Kanter M, Meral I, Yener Z, Ozbek H, Demir H. Partial regeneration/proliferation of the β-cells in the Islets of Langerhans by Nigella sativa L. in streptozotocin-induced diabetic rats. Tohoku Journal of Experimental Medicine. 2003;201(4):213–219.
    1. Kanter M, Coskun O, Korkmaz A, Oter S. Effects of Nigella sativa on oxidative stress and β-cell damage in streptozotocin-induced diabetic rats. Anatomical Record—Part A. 2004;279(1):685–691.
    1. Rchid H, Chevassus H, Nmila R, et al. Nigella sativa seed extracts enhance glucose-induced insulin release from rat-isolated Langerhans islets. Fundamental and Clinical Pharmacology. 2004;18(5):525–529.
    1. Hawsawi ZA, Ali BA, Bamosa AO. Effect of Nigella sativa (black seed) and thymoquinone on blood glucose in albino rats. Annals of Saudi Medicine. 2001;21(3-4):242–244.
    1. Sontakke AN, Tare RS. A duality in the roles of reactive oxygen species with respect to bone metabolism. Clinica Chimica Acta. 2002;318(1-2):145–148.
    1. Maggio D, Barabani M, Pierandrei M, et al. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. Journal of Clinical Endocrinology and Metabolism. 2003;88(4):1523–1527.
    1. Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA. High blood pressure and bone-mineral loss in elderly white women: a prospective study. The Lancet. 1999;354(9183):971–975.
    1. Christensen JO, Svendsen OL. Bone mineral in pre- and postmenopausal women with insulin-dependent and non-insulin-dependent diabetes mellitus. Osteoporosis International. 1999;10(4):307–311.
    1. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. British Medical Journal. 1997;315(7112):841–846.
    1. Basu S, Michaëlsson K, Olofsson H, Johansson S, Melhus H. Association between oxidative stress and bone mineral density. Biochemical and Biophysical Research Communications. 2001;288(1):275–279.
    1. Ahmad NS, Khalid BAK, Luke DA, Nirwana SI. Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone. Clinical and Experimental Pharmacology and Physiology. 2005;32(9):761–770.
    1. Gutteridge JMC, Rowley DA, Halliwell B. Superoxide-dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron salts. Biochemical Journal. 1982;206(3):605–609.
    1. Ebina Y, Okada S, Hamazaki S, Toda Y, Midorikawa O. Impairment of bone formation with aluminum and ferric nitrilotriacetate complexes. Calcified Tissue International. 1991;48(1):28–36.
    1. Takeuchi K, Okada S, Yukihiro S, Inoue H. The inhibitory effects of aluminum and iron on bone formation, in vivo and in vitro study. Pathophysiology. 1997;4(2):97–104.
    1. Garrett IR, Boyce BF, Oreffo ROC, Bonewald L, Poser J, Mundy GR. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo . Journal of Clinical Investigation. 1990;85(3):632–639.
    1. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. Journal of Clinical Investigation. 2001;107(3):241–246.
    1. Nader MA, El-Agamy DS, Suddek GM. Protective effects of propolis and thymoquinone on development of atherosclerosis in cholesterol-fed rabbits. Archives of Pharmacal Research. 2010;33(4):637–643.
    1. Khan N, Sultana S. Inhibition of two stage renal carcinogenesis, oxidative damage and hyperproliterative response by Nigella sativa . European Journal of Cancer Prevention. 2005;14(2):159–168.
    1. Tekeoğlu I, Dogan A, Ediz L, Budancamanak M, Demirel A. Effects of thymoquinone (volatile oil of black cumin) on rheumatoid arthritis in rat models. Phytotherapy Research. 2007;21(9):895–897.
    1. Vaillancourt F, Silva P, Shi Q, Fahmi H, Fernandes JC, Benderdour M. Elucidation of molecular mechanisms underlying the protective effects of thymoquinone against rheumatoid arthritis. Journal of Cellular Biochemistry. 2011;112(1):107–117.
    1. Nazrun AS, Norazlina M, Norliza M, Ima Nirwana S. Comparison of the effects of tocopherol and tocotrienol on osteoporosis in animal models. International Journal of Pharmacology. 2010;6(5):561–568.
    1. Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene. 1999;18(55):7908–7916.
    1. van Ryn J, Trummlitz G, Pairet M. COX-2 selectivity and inflammatory processes. Current Medicinal Chemistry. 2000;7(11):1145–1161.
    1. Houghton PJ, Zarka R, Heras BDL, Hoult JRS. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Medica. 1995;61(1):33–36.
    1. Ghannadi A, Hajhashemi V, Jafarabadi H. An investigation of the analgesic and anti-inflammatory effects of Nigella sativa seed polyphenols. Journal of Medicinal Food. 2005;8(4):488–493.
    1. Mansour M, Tornhamre S. Inhibition of 5-lipoxygenase and leukotriene C4 synthase in human blood cells by thymoquinone. Journal of Enzyme Inhibition and Medicinal Chemistry. 2004;19(5):431–436.
    1. El-Dakhakhny M, Barakat M, Abd El-Halim M, Aly SM. Effects of Nigella sativa oil on gastric secretion and ethanol induced ulcer in rats. Journal of Ethnopharmacology. 2000;72(1-2):299–304.
    1. Suna B, Asha G, Ferhan D, et al. Nigella sativa (black seed) oil does not affect the T-helper 1 and T-helper 2 type cytokine production from splenic mononuclear cells in allergen sensitized mice. Journal of Ethnopharmacology. 2005;100(3):295–298.
    1. Al-Ghamdi MS. The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa . Journal of Ethnopharmacology. 2001;76(1):45–48.
    1. Tanko Y, Mohammed A, Okasha MA, Shuaibu A, Magaji MG, Yaro AH. Analgesic and anti-inflammatory activities of ethanol seed extract of Nigella sativa (black cumin) in mice and rats. European Journal of Scientific Research. 2007;18(2):277–281.
    1. Mitra D, Elvins DM, Speden DJ, Collins AJ. The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology. 2000;39(1):85–89.
    1. Yun AJ, Lee PY. Maldaptation of the link between inflammation and bone turnover may be a key determinant of osteoporosis. Medical Hypotheses. 2004;63(3):532–537.
    1. Hougeberg G, Lodder MC, Lems WF, et al. Hand cortical bone mass and its associations with radiographic joint damage and fractures in 50–70 year old female patients with rheumatoid arthritis: cross sectional Oslo-Truro-Amsterdam (OSTRA) collaborative study. Annals of the Rheumatic Diseases. 2004;63(10):1331–1334.
    1. Bultink IEM, Lems WF, Kostense PJ, Dijkmans BAC, Voskuyl AE. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis and Rheumatism. 2005;52(7):2044–2050.
    1. Mikuls TR, Saag KG, Curtis J, et al. Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: the impact of ethnic-specific normative data. Journal of the National Medical Association. 2005;97(8):1155–1160.
    1. Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Annals of the New York Academy of Sciences. 2000;908:244–254.
    1. Arron JR, Choi Y. Bone versus immune system. Nature. 2000;408(6812):535–536.
    1. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine and Growth Factor Reviews. 2002;13(4-5):357–368.
    1. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(15):9090–9095.
    1. Moschen AR, Kaser A, Enrich B, et al. The RANKL/OPG system is activated in inflammatory bowel diseases and relates to the state or bone loss. Gut. 2005;54(4):479–487.
    1. Saidenberg-Kermanac’h N, Cohen-Solal M, Bessis N, de Vernejoul MC, Boissier MC. Role for osteoprotegerin in rheumatoid inflammation. Joint Bone Spine. 2004;71(1):9–13.
    1. Ozdemir H, Kara MI, Erciyas K, et al. Preventive effects of thymoquinone in a rat periodontitis model: a morphometric and histopathological study. Journal of Periodontal Research. 2012;47(1):74–80.
    1. Kirui PK, Cameron J, Benghuzzi HA, et al. Effects of sustained delivery of thymoqiunone on bone healing of male rats. Biomedical Sciences Instrumentation. 2004;40:111–116.
    1. Kara IM, Erciyas K, Altan AB, et al. Thymoqionone accelerates new bone formation in the rapid maxillary expansion procedure. Archives of Oral Biology. 2012;57(4):357–363.
    1. Zaoui A, Cherrah Y, Mahassini N, Alaoui K, Amarouch H, Hassar M. Acute and chronic toxicity of Nigella sativa fixed oil. Phytomedicine. 2002;9(1):69–74.
    1. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. The FASEB Journal. 2008;22(3):659–661.
    1. Le PM, Benhaddou-Andaloussi A, Elimadi A, Settaf A, Cherrah Y, Haddad PS. The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat. Journal of Ethnopharmacology. 2004;94(2-3):251–259.
    1. Akhtar MS, Riffat S. Field trial of Saussurea lappa roots against nematodes and Nigella sativa seeds against cestodes in children. Journal of the Pakistan Medical Association. 1991;41(8):185–187.
    1. Kalus U, Pruss A, Bystron J, et al. Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases. Phytotherapy Research. 2003;17(10):1209–1214.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner